CVRx ROA 2021-2025 | CVRX

Current and historical return on assets (ROA) values for CVRx (CVRX) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
CVRx ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2025-09-30 $-0.05B $0.11B -42.91%
2025-06-30 $-0.05B $0.12B -41.49%
2025-03-31 $-0.05B $0.13B -42.71%
2024-12-31 $-0.06B $0.13B -51.84%
2024-09-30 $-0.06B $0.13B -52.13%
2024-06-30 $-0.05B $0.10B -51.06%
2024-03-31 $-0.05B $0.11B -47.06%
2023-12-31 $-0.04B $0.12B -35.73%
2023-09-30 $-0.04B $0.11B -36.67%
2023-06-30 $-0.04B $0.12B -35.92%
2023-03-31 $-0.04B $0.12B -33.79%
2022-12-31 $-0.04B $0.13B -31.70%
2022-09-30 $-0.04B $0.13B -30.11%
2022-06-30 $-0.04B $0.13B -24.80%
2022-03-31 $-0.05B $0.14B -33.71%
2021-12-31 $-0.04B $0.15B -45.13%
2021-06-30 $-0.03B $0.06B -218.18%
2021-03-31 $-0.02B $0.00B 0.00%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.175B $0.051B
CVRx Inc. is a commercial-stage medical device company. It focused on developing, manufacturing and commercializing neuromodulation solutions for patients with cardiovascular diseases. CVRx Inc. is headquartered in Minneapolis, MN.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $202.807B 23.60
Intuitive Surgical (ISRG) United States $175.843B 67.83
IDEXX Laboratories (IDXX) United States $51.626B 49.47
Edwards Lifesciences (EW) United States $44.712B 30.10
Alcon (ALC) Switzerland $39.807B 26.83
IQVIA Holdings (IQV) United States $31.071B 16.78
Mettler-Toledo (MTD) United States $28.462B 32.73
DexCom (DXCM) United States $26.584B 36.65
STERIS (STE) Ireland $23.996B 24.27
Waters (WAT) United States $19.473B 24.91
Coloplast (CLPBY) Denmark $17.488B 26.76
Hologic (HOLX) United States $16.777B 17.56
SONOVA HOLDING (SONVY) Switzerland $15.915B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $13.924B 11.55
Penumbra (PEN) United States $13.275B 93.38
Globus Medical (GMED) United States $11.874B 24.92
SARTORIUS (SSSGY) Germany $7.976B 46.32
Masimo (MASI) United States $7.203B 23.08
Glaukos (GKOS) United States $6.492B 0.00
Sysmex ADR (SSMXY) Japan $6.219B 19.76
TransMedics (TMDX) United States $4.760B 56.39
Teleflex (TFX) United States $4.678B 7.45
LivaNova (LIVN) United Kingdom $3.644B 19.68
Integer Holdings (ITGR) United States $3.019B 14.17
Veracyte (VCYT) United States $2.927B 33.36
Elekta AB (EKTAY) Sweden $2.282B 21.34
Alphatec Holdings (ATEC) United States $2.065B 0.00
UFP Technologies (UFPT) United States $2.064B 27.25
Nihon Kohden (NHNKY) Japan $1.967B 21.71
Artivion (AORT) United States $1.911B 87.70
PROCEPT BioRobotics (PRCT) United States $1.674B 0.00
Pulse Biosciences (PLSE) United States $1.621B 0.00
AxoGen (AXGN) United States $1.592B 0.00
IRadimed (IRMD) United States $1.338B 60.09
Tandem Diabetes Care (TNDM) United States $1.325B 0.00
OPKO Health (OPK) United States $0.937B 0.00
Integra LifeSciences Holdings (IART) United States $0.855B 4.63
AVANOS MEDICAL, INC (AVNS) United States $0.683B 13.63
SiBone (SIBN) United States $0.668B 0.00
Beta Bionics (BBNX) United States $0.651B 0.00
Alpha Tau Medical (DRTS) Israel $0.624B 0.00
Tactile Systems Technology (TCMD) United States $0.618B 35.94
Pacific Biosciences Of California (PACB) United States $0.546B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.529B 0.00
NeuroPace (NPCE) United States $0.509B 0.00
Mesa Laboratories (MLAB) United States $0.508B 13.23
AngioDynamics (ANGO) United States $0.454B 0.00
OrthoPediatrics (KIDS) United States $0.428B 0.00
ClearPoint Neuro (CLPT) United States $0.386B 0.00
Delcath Systems (DCTH) United States $0.357B 59.41
RxSight (RXST) United States $0.338B 0.00
Semler Scientific (SMLR) United States $0.311B 2.32
Sight Sciences (SGHT) United States $0.305B 0.00
Spectral Diagnostics (EDTXF) Canada $0.286B 0.00
908 Devices (MASS) United States $0.245B 0.00
Anteris Technologies Global (AVR) Australia $0.239B 0.00
Rapid Micro Biosystems (RPID) United States $0.181B 0.00
EDAP TMS S.A (EDAP) France $0.172B 0.00
Lucid Diagnostics (LUCD) United States $0.167B 0.00
Inogen (INGN) United States $0.156B 0.00
Nano-X Imaging (NNOX) Israel $0.156B 0.00
LENSAR (LNSR) United States $0.148B 0.00
Microbot Medical (MBOT) United States $0.138B 0.00
Treace Medical Concepts (TMCI) United States $0.133B 0.00
Zomedica (ZOMDF) United States $0.127B 0.00
Hyperfine (HYPR) United States $0.106B 0.00
Neuronetics (STIM) United States $0.100B 0.00
Solana (HSDT) United States $0.081B 0.00
Sensus Healthcare (SRTS) United States $0.081B 0.00
QT Imaging Holdings (QTIH) United States $0.078B 0.00
InspireMD (NSPR) United States $0.075B 0.00
DarioHealth (DRIO) United States $0.070B 0.00
QT Imaging Holdings (QTI) United States $0.069B 0.00
Positron (POSC) United States $0.068B 0.00
Accuray (ARAY) United States $0.063B 0.00
Spectral AI (MDAI) United States $0.048B 0.00
Atossa Genetics (ATOS) United States $0.042B 0.00
Precision Optics (POCI) United States $0.040B 0.00
Ekso Bionics Holdings (EKSO) United States $0.026B 0.00
Baird Medical Investment Holdings (BDMD) $0.024B 0.00
Adagio Medical Holdings (ADGM) United States $0.016B 0.00
Vicarious Surgical (RBOT) United States $0.013B 0.00
Check-Cap (MBAI) Israel $0.012B 0.00
Envoy Medical (COCH) United States $0.011B 0.00
PAVmed (PAVM) United States $0.011B 0.00
NexGel (NXGL) United States $0.011B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.011B 0.00
Tenon Medical (TNON) United States $0.009B 0.00
EnVVeno Medical (NVNO) United States $0.006B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
Nanovibronix (NAOV) United States $0.004B 0.00
ENvue Medical (FEED) United States $0.003B 0.00
Autonomix Medical (AMIX) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
WORK Medical Technology Group (WOK) China $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00